169 related articles for article (PubMed ID: 33523278)
1. Laparoscopic radiofrequency ablation of subcapsular hepatocellular carcinomas: risk factors related to a technical failure.
Ko SE; Lee MW; Min JH; Ahn SH; Rhim H; Kang TW; Song KD; Kim JM; Choi GS; Cha DI; Lim HK
Surg Endosc; 2022 Jan; 36(1):504-514. PubMed ID: 33523278
[TBL] [Abstract][Full Text] [Related]
2. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation of subcapsular versus nonsubcapsular hepatocellular carcinomas ≤ 3 cm: analysis of long-term outcomes from two large-volume liver centers.
Han K; Kim JH; Kim GH; Kim JH; Kim SY; Park SH; Moon S; Kwon JH; Kim GM; Lee SJ; Won HJ; Shin YM
Eur Radiol; 2024 Mar; 34(3):1578-1586. PubMed ID: 37646813
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic Hepatic Resection Versus Laparoscopic Radiofrequency Ablation for Subcapsular Hepatocellular Carcinomas Smaller Than 3 cm: Analysis of Treatment Outcomes Using Propensity Score Matching.
Ko SE; Lee MW; Ahn S; Rhim H; Kang TW; Song KD; Kim JM; Choi GS; Cha DI; Min JH; Sinn DH; Choi MS; Lim HK
Korean J Radiol; 2022 Jun; 23(6):615-624. PubMed ID: 35289151
[TBL] [Abstract][Full Text] [Related]
6. Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcome.
Kim JH; Lee JY; Yu SJ; Lee DH; Joo I; Yoon JH; Kim YJ; Yoon JH; Lee JM
Int J Hyperthermia; 2023; 40(1):2213424. PubMed ID: 37253458
[No Abstract] [Full Text] [Related]
7. Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
Lee DH; Lee MW; Kim PN; Lee YJ; Park HS; Lee JM
Radiology; 2021 Oct; 301(1):229-236. PubMed ID: 34313474
[TBL] [Abstract][Full Text] [Related]
8. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation.
Lee DH; Lee JM; Yoon JH; Kim YJ; Han JK
Radiology; 2017 Mar; 282(3):880-891. PubMed ID: 27643670
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Laparoscopic Microwave to Radiofrequency Ablation of Small Hepatocellular Carcinoma (≤3 cm).
Santambrogio R; Chiang J; Barabino M; Meloni FM; Bertolini E; Melchiorre F; Opocher E
Ann Surg Oncol; 2017 Jan; 24(1):257-263. PubMed ID: 27581608
[TBL] [Abstract][Full Text] [Related]
10. No-Touch vs. Conventional Radiofrequency Ablation Using Twin Internally Cooled Wet Electrodes for Small Hepatocellular Carcinomas: A Randomized Prospective Comparative Study.
Suh YS; Choi JW; Yoon JH; Lee DH; Kim YJ; Lee JH; Yu SJ; Cho EJ; Yoon JH; Lee JM
Korean J Radiol; 2021 Dec; 22(12):1974-1984. PubMed ID: 34668352
[TBL] [Abstract][Full Text] [Related]
11. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
[TBL] [Abstract][Full Text] [Related]
12. Treatment Outcomes of Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: Effects of the Electrode Type and Placement Method.
Park J; Lee MW; Ahn SH; Han S; Min JH; Cha DI; Song KD; Kang TW; Rhim H
Korean J Radiol; 2023 Aug; 24(8):761-771. PubMed ID: 37500577
[TBL] [Abstract][Full Text] [Related]
13. Safety margin for CT- and US-guided radiofrequency ablation after TACE of HCC in the hepatic dome.
Mitani H; Naito A; Chosa K; Kodama H; Sumida M; Moriya T; Awai K
Minim Invasive Ther Allied Technol; 2022 Aug; 31(6):894-901. PubMed ID: 34726557
[TBL] [Abstract][Full Text] [Related]
14. Can "no-touch" radiofrequency ablation for hepatocellular carcinoma improve local tumor control? Systematic review and meta-analysis.
Kim TH; Lee JM; Lee DH; Joo I; Park SJ; Yoon JH
Eur Radiol; 2023 Jan; 33(1):545-554. PubMed ID: 35907024
[TBL] [Abstract][Full Text] [Related]
15. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with increased risk of peritoneal seeding after radiofrequency ablation for hepatocellular carcinoma.
Ryu H; Kim TU; Lee JW; Jeon UB; Kim JH; Jang JY; Yoon KT; Hong YM
Abdom Radiol (NY); 2023 Oct; 48(10):3243-3252. PubMed ID: 37389604
[TBL] [Abstract][Full Text] [Related]
17. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
18. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Radiofrequency Ablation for Early Hypovascular HCC: A Multicenter Retrospective Study.
Lee DH; Lee JM; Kang TW; Rhim H; Kim SY; Shin YM; Seo JW; Choi MH; Lee KB
Radiology; 2018 Jan; 286(1):338-349. PubMed ID: 28981400
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
